BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25103678)

  • 1. Improving hospital performance in the treatment of febrile neutropenia.
    Meisenberg B; Clemons J; Ness J; Faust N; Clance M
    Support Care Cancer; 2015 Feb; 23(2):371-5. PubMed ID: 25103678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emergency Department Management of Patients With Febrile Neutropenia: Guideline Concordant or Overly Aggressive?
    Baugh CW; Wang TJ; Caterino JM; Baker ON; Brooks GA; Reust AC; Pallin DJ
    Acad Emerg Med; 2017 Jan; 24(1):83-91. PubMed ID: 27611638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nurse-initiated pre-prescribed antibiotic orders to facilitate prompt and appropriate antibiotic administration in febrile neutropenia.
    Walker ST; Grigg S; Kirkpatrick C; Urbancic K; Cohen E; Grigg A; Trubiano J
    Support Care Cancer; 2020 Sep; 28(9):4337-4343. PubMed ID: 31912358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Winter 2017 Children's Cancer and Leukaemia Group febrile neutropenia audit.
    Morgan JE; Phillips B
    Arch Dis Child; 2018 Dec; 103(12):1187. PubMed ID: 29705724
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of febrile neutropenia in solid organ malignancies following chemotherapy.
    Lakshmaiah KC; Abhayakumar SM; Shetty R; Loknath D; Jayashree RS; Govindbabu K
    J Cancer Res Ther; 2014; 10(3):540-3. PubMed ID: 25313735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness analysis of the 2018 ASCO/IDSA guideline for outpatient management of fever and neutropenia in adults treated for malignancy.
    Hwang S; Kwon KT; Kim Y; Bae S; Chang HH; Kim SW; Yoo SS; Nam SY; Baek JH
    Sci Rep; 2021 Sep; 11(1):9048. PubMed ID: 34526516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reducing Overuse of Colony-Stimulating Factors in Patients With Lung Cancer Receiving Chemotherapy: Evidence From a Decision Support-Enabled Program.
    Adeboyeje G; Agiro A; Malin J; Fisch MJ; DeVries A
    J Oncol Pract; 2017 Apr; 13(4):e337-e345. PubMed ID: 28260403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Making Improvements in the ED: Does ED Busyness Affect Time to Antibiotics in Febrile Pediatric Oncology Patients Presenting to the Emergency Department?
    Benner CA; Mora E; Mueller E; Seagull FJ; Walkovich K; Johnson K; Halverson S; Rothman E; Hucks G; Younger JG; Nypaver MM
    Pediatr Emerg Care; 2018 May; 34(5):310-316. PubMed ID: 27749799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febrile neutropenia risk assessment tool: improving clinical outcomes for oncology patients.
    O'Brien C; Dempsey O; Kennedy MJ
    Eur J Oncol Nurs; 2014 Apr; 18(2):167-74. PubMed ID: 24290035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for febrile neutropenia among patients with cancer receiving chemotherapy: A systematic review.
    Lyman GH; Abella E; Pettengell R
    Crit Rev Oncol Hematol; 2014 Jun; 90(3):190-9. PubMed ID: 24434034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients.
    Kamonrattana R; Sathitsamitphong L; Choeyprasert W; Charoenkwan P; Natesirinilkul R; Fanhchaksai K
    Asian Pac J Cancer Prev; 2019 Sep; 20(9):2733-2737. PubMed ID: 31554370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of febrile neutropenia in pediatric oncology across Queensland, Australia: a retrospective review on variations between locations.
    Cox A; Bradford N
    J Pediatr Oncol Nurs; 2014; 31(1):28-33. PubMed ID: 24378817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addressing the barriers to optimal management of febrile neutropenia in children with cancer.
    Anderson K; Bradford N; Edwards R; Nicholson J; Lockwood L; Clark J
    Eur J Oncol Nurs; 2020 Apr; 45():101719. PubMed ID: 32163859
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of fever and neutropenia in children with cancer.
    Vedi A; Pennington V; O'Meara M; Stark K; Senner A; Hunstead P; Adnum K; Londall W; Maurice L; Wakefield C; Cohn RJ
    Support Care Cancer; 2015 Jul; 23(7):2079-87. PubMed ID: 25533581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of fever and neutropenia in children with cancer: A survey of Australian and New Zealand practice.
    Haeusler GM; Slavin MA; Bryant PA; Babl FE; Mechinaud F; Thursky KA
    J Paediatr Child Health; 2018 Jul; 54(7):761-769. PubMed ID: 29655245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Fever Advisory Cards (FACs) as an Initiative to Improve Febrile Neutropenia Management in a Regional Cancer Center Emergency Department.
    Kapil P; MacMillan M; Carvalho M; Lymburner P; Fung R; Almeida B; Van Dorn L; Enright K
    J Oncol Pract; 2016 Sep; 12(9):e858-63. PubMed ID: 27486160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review.
    Fernandes R; Mazzarello S; Stober C; Vandermeer L; Dudani S; Ibrahim MF; Majeed H; Perdrizet K; Shorr R; Hutton B; Fergusson D; Clemons M
    Breast Cancer Res Treat; 2017 Jan; 161(1):1-10. PubMed ID: 27783280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of effectiveness of biosimilar filgrastim (Nivestimâ„¢), reference Amgen filgrastim and pegfilgrastim in febrile neutropenia primary prevention in breast cancer patients treated with neo(adjuvant) TAC: a non-interventional cohort study.
    Brito M; Esteves S; André R; Isidoro M; Moreira A
    Support Care Cancer; 2016 Feb; 24(2):597-603. PubMed ID: 26111956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reducing Time to Antibiotic Administration for Febrile Neutropenia in the Emergency Department.
    Keng MK; Thallner EA; Elson P; Ajon C; Sekeres J; Wenzell CM; Seastone DJ; Gallagher EM; Weber CM; Earl MA; Mukherjee S; Pohlman B; Cober E; Foster VB; Yuhas J; Kalaycio ME; Bolwell BJ; Sekeres MA
    J Oncol Pract; 2015 Nov; 11(6):450-5. PubMed ID: 26220930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of initial antibiotic treatment for febrile neutropenia in the emergency department: the need for evidence-based guidelines.
    Kyriacou DN; Jovanovic B; Frankfurt O
    J Natl Compr Canc Netw; 2014 Nov; 12(11):1569-73. PubMed ID: 25361804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.